FTD and ALS: a tale of two diseases - PubMed (original) (raw)
Review
FTD and ALS: a tale of two diseases
R Ferrari et al. Curr Alzheimer Res. 2011 May.
Abstract
The first reports of disorders that in terms of cognitive and behavioral symptoms resemble frontotemporal dementia (FTD) and in terms of motor symptoms resemble amyotrophic lateral sclerosis (ALS) bring us back to the second half of the 1800s. Over the last 150 years, and especially in the last two decades, there has been growing evidence that FTD signs can be seen in patients primarily diagnosed with ALS, implying clinical overlap among these two disorders. In the last decade pathological investigations and genetic screening have contributed tremendously in elucidating the pathology and genetic variability associated with FTD and ALS. To the most important recentdiscoveries belong TAR DNA binding protein [TARDBP or TDP-43] and the fused in sarcoma gene [FUS] and their implication in these disorders.FTD and ALS are the focus of this review which aims to 1. summarize clinical features by describing the diagnostic criteria and specific symptomatology, 2. describe the morphological aspects and related pathology, 3. describe the genetic factors associated with the diseases and 4. summarize the current status of clinical trials and treatment options. A better understanding of the clinical, pathological and genetic features characterizing FTD and ALS will shed light into overlaps among these two disorders and the underpinning mechanisms that contribute to the onset and development. Nevertheless, advancements in the knowledge of the biology of these two disorders will help developing novel and, hopefully, more effective diagnostic and treatment options.
Conflict of interest statement
Conflict of interest
Authors declare no conflicts of interest.
Figures
Figure 1
Similar articles
- The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E, Gao FB. Gascon E, et al. J Neurogenet. 2014 Mar-Jun;28(1-2):30-40. doi: 10.3109/01677063.2013.876021. Epub 2014 Feb 10. J Neurogenet. 2014. PMID: 24506814 Free PMC article. Review. - Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
Fecto F, Siddique T. Fecto F, et al. J Mol Neurosci. 2011 Nov;45(3):663-75. doi: 10.1007/s12031-011-9637-9. Epub 2011 Sep 7. J Mol Neurosci. 2011. PMID: 21901496 Review. - Clinical phenomenology and neuroimaging correlates in ALS-FTD.
Lomen-Hoerth C. Lomen-Hoerth C. J Mol Neurosci. 2011 Nov;45(3):656-62. doi: 10.1007/s12031-011-9636-x. Epub 2011 Oct 5. J Mol Neurosci. 2011. PMID: 21971978 Review. - Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW. Murray ME, et al. Acta Neuropathol. 2011 Dec;122(6):673-90. doi: 10.1007/s00401-011-0907-y. Epub 2011 Nov 15. Acta Neuropathol. 2011. PMID: 22083254 Free PMC article. - Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM. Liščić RM. Arh Hig Rada Toksikol. 2015 Dec;66(4):285-90. doi: 10.1515/aiht-2015-66-2679. Arh Hig Rada Toksikol. 2015. PMID: 26751860 Review.
Cited by
- Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations.
Konopka A, Whelan DR, Jamali MS, Perri E, Shahheydari H, Toth RP, Parakh S, Robinson T, Cheong A, Mehta P, Vidal M, Ragagnin AMG, Khizhnyak I, Jagaraj CJ, Galper J, Grima N, Deva A, Shadfar S, Nicholson GA, Yang S, Cutts SM, Horejsi Z, Bell TDM, Walker AK, Blair IP, Atkin JD. Konopka A, et al. Mol Neurodegener. 2020 Sep 9;15(1):51. doi: 10.1186/s13024-020-00386-4. Mol Neurodegener. 2020. PMID: 32907630 Free PMC article. - Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease.
Izrael M, Slutsky SG, Revel M. Izrael M, et al. Front Neurosci. 2020 Jul 28;14:824. doi: 10.3389/fnins.2020.00824. eCollection 2020. Front Neurosci. 2020. PMID: 32848579 Free PMC article. Review. - Social Cognition through the Lens of Cognitive and Clinical Neuroscience.
Arioli M, Crespi C, Canessa N. Arioli M, et al. Biomed Res Int. 2018 Sep 13;2018:4283427. doi: 10.1155/2018/4283427. eCollection 2018. Biomed Res Int. 2018. PMID: 30302338 Free PMC article. Review. - SQSTM1/p62: A Potential Target for Neurodegenerative Disease.
Ma S, Attarwala IY, Xie XQ. Ma S, et al. ACS Chem Neurosci. 2019 May 15;10(5):2094-2114. doi: 10.1021/acschemneuro.8b00516. Epub 2019 Apr 19. ACS Chem Neurosci. 2019. PMID: 30657305 Free PMC article. Review. - Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants.
De Marchi F, Tondo G, Corrado L, Menegon F, Aprile D, Anselmi M, D'Alfonso S, Comi C, Mazzini L. De Marchi F, et al. Genes (Basel). 2023 Aug 21;14(8):1658. doi: 10.3390/genes14081658. Genes (Basel). 2023. PMID: 37628709 Free PMC article. Review.
References
- Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54. - PubMed
- Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology. 2004;62:506–8. - PubMed
- Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21. - PubMed
- Berrios GE, Girling DM. Introduction: Pick’s disease and the ‘frontal lobe’ dementias. Hist Psychiatry. 1994;5:539–47. - PubMed
Publication types
MeSH terms
Grants and funding
- K12 AG000975/AG/NIA NIH HHS/United States
- R99 AG999999/AG/NIA NIH HHS/United States
- Z99 AG999999/ImNIH/Intramural NIH HHS/United States
- ZIA AG000975/ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous